Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDC80 kinetochore complex component (commonly referred to as NDC80 or HEC1 in humans) is a highly conserved structural protein that is an essential subunit of the NDC80 complex, a heterotetrameric core complex forming the principal connection between spindle microtubules and centromeres during mitosis[1][2][3]. The human NDC80 complex consists of NDC80 (HEC1), NUF2, SPC24, and SPC25; together, they form an elongated rod-like structure with calponin-homology domains on the NDC80/NUF2 end for microtubule attachment and RWD domains on the SPC24/SPC25 end interacting with inner kinetochore proteins[1][2]. The complex ensures proper chromosome alignment, biorientation, and segregation, thus maintaining genomic stability; its dynamic regulation, via conformational changes and phosphorylation, is critical to correct kinetochore-microtubule attachments and spindle checkpoint signaling[1][3]. NDC80 is highly expressed in many human cancers and is being investigated both as a prognostic biomarker and as a potential therapeutic target to induce mitotic catastrophe selectively in rapidly dividing tumor cells[1][3]. However, due to its ubiquitous role in cell division, therapeutic targeting poses significant toxicity risks.
Inhibition of kinetochore-microtubule attachment (mechanism for experimental inhibitors/antibodies) Disruption of NDC80 complex function leads to mitotic arrest and apoptosis in rapidly dividing cells (mainly cancer cell models)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NDC80 kinetochore complex component (NDC80).